The potential impact of new generation transgenic methods on creating rabbit models of cardiac diseases

Progress in Biophysics and Molecular Biology

Volumn 121, Issue 2, 2016, Pages 123-130

  Bosze Z ^a   Major, P ^a   Baczko I ^b   Odening, K E ^c   Bodrogi, L ^a,b   Hiripi, L ^a   Varro A ^b  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Designer nucleases; Knock in; Knockout; Sleeping beauty transposon; Transgenic rabbit

Indexed keywords

TRANSPOSON;

ANIMAL; DISEASE MODEL; GENE TRANSFER; GENETICS; GENOMICS; HEART DISEASE; HUMAN; RABBIT; TRANSGENIC ANIMAL; TRANSPOSON;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DNA TRANSPOSABLE ELEMENTS; GENE TRANSFER TECHNIQUES; GENOMICS; HEART DISEASES; HUMANS; RABBITS;

EID: 84970005323     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2016.05.007     Document Type: Review

References (68)

1. Baczko, I., Jost, N., Virag, L., Bosze, Z., Varro, A., Rabbit models as tools for preclinical cardiac electrophysiological safety testing: importance of repolarization reserve. Prog Biophys Mol Biol 121/2 (2016), 157–168.
2. Bibikova, M., Carroll, D., Segal, D.J., Trautman, J.K., Smith, J., Kim, Y.G., Chandrasegaran, S., Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol. Cell Biol. 21 (2001), 289–297.
3. Bolotin, A., Quinquis, B., Sorokin, A., Ehrlich, S.D., Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151 (2005), 2551–2561.
4. Boullier, A., Hennuyer, N., Tailleux, A., Furman, C., Duverger, N., Caillaud, J.M., Castro, G., Fievet, C., Fruchart, J.C., Duriez, P., Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia. Clin. Sci. Lond. 100 (2001), 343–355.
5. Bround, M.J., Asghari, P., Wambolt, R.B., Bohunek, L., Smits, C., Philit, M., Kieffer, T.J., Lakatta, E.G., Boheler, K.R., Moore, E.D., Allard, M.F., Johnson, J.D., Cardiac ryanodine receptors control heart rate and rhythmicity in adult mice. Cardiovasc Res. 96 (2012), 372–380.
6. Brunner, M., Peng, X., Liu, G.X., Ren, X.Q., Ziv, O., Choi, B.R., Mathur, R., Hajjiri, M., Odening, K.E., Steinberg, E., Folco, E.J., Pringa, E., Centracchio, J., Macharzina, R.R., Donahay, T., Schofield, L., Rana, N., Kirk, M., Mitchell, G.F., Poppas, A., Zehender, M., Koren, G., Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J. Clin. Investig. 118 (2008), 2246–2259.
7. Charpentier, E., Doudna, J.A., Biotechnology: rewriting a genome. Nature 495 (2013), 50–51.
8. Choi, J.G., Dang, Y., Abraham, S., Ma, H., Zhang, J., Guo, H., Cai, Y., Mikkelsen, J.G., Wu, H., Shankar, P., Manjunath, N., Lentivirus pre-packed with Cas9 protein for safer gene editing. Gene Ther., 2016, 10.1038/gt.2016.27 [Epub ahead of print].
9. Decker, J.A., Rossano, J.W., Smith, E.O., Cannon, B., Clunie, S.K., Gates, C., Jefferies, J.L., Kim, J.J., Price, J.F., Dreyer, W.J., Towbin, J.A., Denfield, S.W., Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J. Am. Coll. Cardiol. 54 (2009), 250–254.
10. Ding, Y., Wang, Y., Zhu, H., Fan, J., Yu, L., Liu, G., Liu, E., Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII. Transgenic Res. 20 (2011), 867–875.
11. Duranthon, V., Beaujean, N., Brunner, M., Odening, K.E., Santos, A.N., Kacskovics, I., Hiripi, L., Weinstein, E.J., Bosze, Z., On the emerging role of rabbit as human disease model and the instrumental role of novel transgenic tools. Transgenic Res. 21 (2012), 699–713.
12. Duverger, N., Kruth, H., Emmanuel, F., Caillaud, J.M., Viglietta, C., Castro, G., Tailleux, A., Fievet, C., Fruchart, J.C., Houdebine, L.M., Denefle, P., Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 94 (1996), 713–717.
13. Fan, J., Wang, J., Bensadoun, A., Lauer, S.J., Dang, Q., Mahley, R.W., Taylor, J.M., Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 8724–8728.
14. Fan, J., McCormick, S.P., Krauss, R.M., Taylor, S., Quan, R., Taylor, J.M., Young, S.G., Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL. Arterioscler. Thromb. Vasc. Biol. 15 (1995), 1889–1899.
15. Fan, J., Ji, Z.S., Huang, Y., de Silva, H., Sanan, D., Mahley, R.W., Innerarity, T.L., Taylor, J.M., Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J. Clin. Investig. 101 (1998), 2151–2164.
16. Fan, J., Shimoyamada, H., Sun, H., Marcovina, S., Honda, K., Watanabe, T., Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet. Arterioscler. Thromb. Vasc. Biol. 21 (2001), 88–94.
17. Fan, J., Kitajima, S., Watanabe, T., Xu, J., Zhang, J., Liu, E., Chen, Y.E., Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol. Ther. 146 (2015), 104–119.
18. Febbraio, M., Podrez, E.A., Smith, J.D., Hajjar, D.P., Hazen, S.L., Hoff, H.F., Sharma, K., Silverstein, R.L., Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Investig. 105 (2000), 1049–1056.
19. Flisikowska, T., Thorey, I.S., Offner, S., Ros, F., Lifke, V., Zeitler, B., Rottmann, O., Vincent, A., Zhang, L., Jenkins, S., Niersbach, H., Kind, A.J., Gregory, P.D., Schnieke, A.E., Platzer, J., Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS One, 6, 2011, e21045.
20. Grabundzija, I., Irgang, M., Mates, L., Belay, E., Matrai, J., Gogol-Doring, A., Kawakami, K., Chen, W., Ruiz, P., Chuah, M.K., VandenDriessche, T., Izsvak, Z., Ivics, Z., Comparative analysis of transposable element vector systems in human cells. Mol. Ther. 18 (2010), 1200–1209.
21. Hammer, R.E., Pursel, V.G., Rexroad, C.E. Jr., Wall, R.J., Bolt, D.J., Ebert, K.M., Palmiter, R.D., Brinster, R.L., Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315 (1985), 680–683.
22. Haurwitz, R.E., Jinek, M., Wiedenheft, B., Zhou, K., Doudna, J.A., Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 329 (2010), 1355–1358.
23. Hoeg, J.M., Santamarina-Fojo, S., Berard, A.M., Cornhill, J.F., Herderick, E.E., Feldman, S.H., Haudenschild, C.C., Vaisman, B.L., Hoyt, R.F. Jr., Demosky, S.J. Jr., Kauffman, R.D., Hazel, C.M., Marcovina, S.M., Brewer, H.B. Jr., Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 11448–11453.
24. Huang, Y., Schwendner, S.W., Rall, S.C. Jr., Sanan, D.A., Mahley, R.W., Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis. J. Biol. Chem. 272 (1997), 22685–22694.
25. Ichikawa, T., Kitajima, S., Liang, J., Koike, T., Wang, X., Sun, H., Okazaki, M., Morimoto, M., Shikama, H., Watanabe, T., Yamada, N., Fan, J., Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis. Lab. Investig. 84 (2004), 715–726.
26. Ishibashi, S., Brown, M.S., Goldstein, J.L., Gerard, R.D., Hammer, R.E., Herz, J., Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Investig. 92 (1993), 883–893.
27. Ivics, Z., Hiripi, L., Hoffmann, O.I., Mates, L., Yau, T.Y., Bashir, S., Zidek, V., Landa, V., Geurts, A., Pravenec, M., Rulicke, T., Bosze, Z., Izsvak, Z., Germline transgenesis in rabbits by pronuclear microinjection of Sleeping Beauty transposons. Nat. Protoc. 9 (2014), 794–809.
28. Izsvak, Z., Ivics, Z., Plasterk, R.H., Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J. Mol. Biol. 302 (2000), 93–102.
29. James, J., Sanbe, A., Yager, K., Martin, L., Klevitsky, R., Robbins, J., Genetic manipulation of the rabbit heart via transgenesis. Circulation 101 (2000), 1715–1721.
30. Ji, D., Zhao, G., Songstad, A., Cui, X., Weinstein, E.J., Efficient creation of an APOE knockout rabbit. Transgenic Res. 24 (2015), 227–235.
31. Joung, J.K., Sander, J.D., TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14 (2013), 49–55.
32. Katter, K., Geurts, A.M., Hoffmann, O., Mates, L., Landa, V., Hiripi, L., Moreno, C., Lazar, J., Bashir, S., Zidek, V., Popova, E., Jerchow, B., Becker, K., Devaraj, A., Walter, I., Grzybowksi, M., Corbett, M., Filho, A.R., Hodges, M.R., Bader, M., Ivics, Z., Jacob, H.J., Pravenec, M., Bosze, Z., Rulicke, T., Izsvak, Z., Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits. FASEB J. 27 (2013), 930–941.
33. Kitajima, S., Liu, E., Morimoto, M., Koike, T., Yu, Y., Watanabe, T., Imagawa, S., Fan, J., Transgenic rabbits with increased VEGF expression develop hemangiomas in the liver: a new model for Kasabach-Merritt syndrome. Lab. Investig. 85 (2005), 1517–1527.
34. Kitajima, S., Jin, Y., Koike, T., Yu, Y., Liu, E., Shiomi, M., Marcovina, S.M., Morimoto, M., Watanabe, T., Fan, J., Lp(a) enhances coronary atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 193 (2007), 269–276.
35. Kleinstiver, B.P., Pattanayak, V., Prew, M.S., Tsai, S.Q., Nguyen, N.T., Zheng, Z., Joung, J.K., High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529 (2016), 490–495.
36. Koike, T., Kitajima, S., Yu, Y., Li, Y., Nishijima, K., Liu, E., Sun, H., Waqar, A.B., Shibata, N., Inoue, T., Wang, Y., Zhang, B., Kobayashi, J., Morimoto, M., Saku, K., Watanabe, T., Fan, J., Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 2047–2053.
37. Lang, C.N., Koren, G., Odening, K.E., Transgenic rabbit models to investigate the cardiac ion channel disease long QT syndrome. Prog Biophys Mol Biol 121/2 (2016), 142–156.
38. Liang, J., Liu, E., Yu, Y., Kitajima, S., Koike, T., Jin, Y., Morimoto, M., Hatakeyama, K., Asada, Y., Watanabe, T., Sasaguri, Y., Watanabe, S., Fan, J., Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation 113 (2006), 1993–2001.
39. Lieber, M.R., The biochemistry and biological significance of nonhomologous DNA end joining: an essential repair process in multicellular eukaryotes. Genes Cells 4 (1999), 77–85.
40. Liu, E., Morimoto, M., Kitajima, S., Koike, T., Yu, Y., Shiiki, H., Nagata, M., Watanabe, T., Fan, J., Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J. Am. Soc. Nephrol. 18 (2007), 2094–2104.
41. Major, P., Baczko, I., Hiripi, L., Odening, K.E., Juhasz, V., Kohajda, Z., Horvath, A., Seprenyi, G., Kovacs, M., Virag, L., Jost, N., Prorok, J., Ordog, B., Doleschall, Z., Nattel, S., Varro, A., Bosze, Z., A novel transgenic rabbit model with reduced repolarization reserve: long QT syndrome caused by a dominant-negative mutation of KCNE1 gene. Br. J. Pharmacol., 2016, 10.1111/bph.13500 [Epub ahead of print].
42. Mani, M., Smith, J., Kandavelou, K., Berg, J.M., Chandrasegaran, S., Binding of two zinc finger nuclease monomers to two specific sites is required for effective double-strand DNA cleavage. Biochem. Biophys. Res. Commun. 334 (2005), 1191–1197.
43. Marian, A.J., Wu, Y., Lim, D.S., McCluggage, M., Youker, K., Yu, Q.T., Brugada, R., DeMayo, F., Quinones, M., Roberts, R., A transgenic rabbit model for human hypertrophic cardiomyopathy. J. Clin. Investig. 104 (1999), 1683–1692.
44. Marian, A.J., On mice, rabbits, and human heart failure. Circulation 111 (2005), 2276–2279.
45. Masson, D., Deckert, V., Gautier, T., Klein, A., Desrumaux, C., Viglietta, C., Pais de Barros, J.P., Le Guern, N., Grober, J., Labbe, J., Menetrier, F., Ripoll, P.J., Leroux-Coyau, M., Jolivet, G., Houdebine, L.M., Lagrost, L., Worsening of diet-induced atherosclerosis in a new model of transgenic rabbit expressing the human plasma phospholipid transfer protein. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 766–774.
46. Mates, L., Chuah, M.K., Belay, E., Jerchow, B., Manoj, N., Acosta-Sanchez, A., Grzela, D.P., Schmitt, A., Becker, K., Matrai, J., Ma, L., Samara-Kuko, E., Gysemans, C., Pryputniewicz, D., Miskey, C., Fletcher, B., VandenDriessche, T., Ivics, Z., Izsvak, Z., Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet. 41 (2009), 753–761.
47. Matsuda, S., Yamashita, A., Sato, Y., Kitajima, S., Koike, T., Sugita, C., Moriguchi-Goto, S., Hatakeyama, K., Takahashi, M., Koshimoto, C., Matsuura, Y., Iwakiri, T., Chen, Y.E., Fan, J., Asada, Y., Human C-reactive protein enhances thrombus formation after neointimal balloon injury in transgenic rabbits. J. Thromb. Haemost. 9 (2011), 201–208.
48. Miller, I., Rogel-Gaillard, C., Spina, D., Fontanesi, L., de Almeida, A.M., The rabbit as an experimental and production animal: from genomics to proteomics. Curr. Protein Pept. Sci. 15 (2014), 134–145.
49. Odening, K.E., Hyder, O., Chaves, L., Schofield, L., Brunner, M., Kirk, M., Zehender, M., Peng, X., Koren, G., Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H2264–H2272.
50. Patel, R., Nagueh, S.F., Tsybouleva, N., Abdellatif, M., Lutucuta, S., Kopelen, H.A., Quinones, M.A., Zoghbi, W.A., Entman, M.L., Roberts, R., Marian, A.J., Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation 104 (2001), 317–324.
51. Reis, A.H., Macdonald, B.T., Feistel, K., Brito, J.M., Amado, N.G., Xu, C., Abreu, J.G., He, X., Expression and evolution of the Tiki1 and Tiki2 genes in vertebrates. Int. J. Dev. Biol. 58 (2014), 355–362.
52. Rouy, D., Duverger, N., Lin, S.D., Emmanuel, F., Houdebine, L.M., Denefle, P., Viglietta, C., Gong, E., Rubin, E.M., Hughes, S.D., Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein B. J. Biol. Chem. 273 (1998), 1247–1251.
53. Sanbe, A., James, J., Tuzcu, V., Nas, S., Martin, L., Gulick, J., Osinska, H., Sakthivel, S., Klevitsky, R., Ginsburg, K.S., Bers, D.M., Zinman, B., Lakatta, E.G., Robbins, J., Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Circulation 111 (2005), 2330–2338.
54. Senthil, V., Chen, S.N., Tsybouleva, N., Halder, T., Nagueh, S.F., Willerson, J.T., Roberts, R., Marian, A.J., Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ. Res. 97 (2005), 285–292.
55. Sharma, R., Anguela, X.M., Doyon, Y., Wechsler, T., DeKelver, R.C., Sproul, S., Paschon, D.E., Miller, J.C., Davidson, R.J., Shivak, D., Zhou, S., Rieders, J., Gregory, P.D., Holmes, M.C., Rebar, E.J., High, K.A., In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126 (2015), 1777–1784.
56. Shen, J., Kuhn, H., Petho-Schramm, A., Chan, L., Transgenic rabbits with the integrated human 15-lipoxygenase gene driven by a lysozyme promoter: macrophage-specific expression and variable positional specificity of the transgenic enzyme. FASEB J. 9 (1995), 1623–1631.
57. Shen, J., Herderick, E., Cornhill, J.F., Zsigmond, E., Kim, H.S., Kuhn, H., Guevara, N.V., Chan, L., Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J. Clin. Investig. 98 (1996), 2201–2208.
58. Song, J., Zhong, J., Guo, X., Chen, Y., Zou, Q., Huang, J., Li, X., Zhang, Q., Jiang, Z., Tang, C., Yang, H., Liu, T., Li, P., Pei, D., Lai, L., Generation of RAG 1- and 2-deficient rabbits by embryo microinjection of TALENs. Cell Res. 23 (2013), 1059–1062.
59. Streubel, J., Blucher, C., Landgraf, A., Boch, J., TAL effector RVD specificities and efficiencies. Nat. Biotechnol. 30 (2012), 593–595.
60. Suzuki, T., Palmer, B.M., James, J., Wang, Y., Chen, Z., VanBuren, P., Maughan, D.W., Robbins, J., LeWinter, M.M., Effects of cardiac myosin isoform variation on myofilament function and crossbridge kinetics in transgenic rabbits. Circ. Heart Fail. 2 (2009), 334–341.
61. Tebas, P., Stein, D., Tang, W.W., Frank, I., Wang, S.Q., Lee, G., Spratt, S.K., Surosky, R.T., Giedlin, M.A., Nichol, G., Holmes, M.C., Gregory, P.D., Ando, D.G., Kalos, M., Collman, R.G., Binder-Scholl, G., Plesa, G., Hwang, W.T., Levine, B.L., June, C.H., Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N. Engl. J. Med. 370 (2014), 901–910.
62. Yamada, S., Wang, K.Y., Tanimoto, A., Fan, J., Shimajiri, S., Kitajima, S., Morimoto, M., Tsutsui, M., Watanabe, T., Yasumoto, K., Sasaguri, Y., Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. Am. J. Pathol. 172 (2008), 1419–1429.
63. Yamanaka, S., Balestra, M.E., Ferrell, L.D., Fan, J., Arnold, K.S., Taylor, S., Taylor, J.M., Innerarity, T.L., Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 8483–8487.
64. Yan, Q., Zhang, Q., Yang, H., Zou, Q., Tang, C., Fan, N., Lai, L., Generation of multi-gene knockout rabbits using the Cas9/gRNA system. Cell Regen. Lond., 3, 2014, 12.
65. Yang, D., Zhang, J., Xu, J., Zhu, T., Fan, Y., Fan, J., Chen, Y.E., Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases. J. Vis. Exp., 2013, e50957.
66. Yang, D., Xu, J., Zhu, T., Fan, J., Lai, L., Zhang, J., Chen, Y.E., Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. J. Mol. Cell Biol. 6 (2014), 97–99.
67. Yin, M., Jiang, W., Fang, Z., Kong, P., Xing, F., Li, Y., Chen, X., Li, S., Generation of hypoxanthine phosphoribosyltransferase gene knockout rabbits by homologous recombination and gene trapping through somatic cell nuclear transfer. Sci. Rep., 5, 2015, 16023.
68. Zakhartchenko, V., Flisikowska, T., Li, S., Richter, T., Wieland, H., Durkovic, M., Rottmann, O., Kessler, B., Gungor, T., Brem, G., Kind, A., Wolf, E., Schnieke, A., Cell-mediated transgenesis in rabbits: chimeric and nuclear transfer animals. Biol. Reprod. 84 (2011), 229–237.